Credible assumptions replace missing data in COVID analysis

Cornell University
6-Aug-2020 12:40 PM EDT, by Cornell University

Newswise — ITHACA, N.Y. – How contagious is COVID-19, and how severe is the virus for those who’ve caught it?

Everyone wants firm numbers as schools make decisions about in-person versus remote learning, as local and state governments grapple with reopening, and as families care for sick loved ones.

But firm data is missing, said Francesca Molinari, the H.T. Warshow and Robert Irving Warshow Professor in the Department of Economics, in the College of Arts and Sciences. The best way to find out the share of the population that has been exposed to the virus is to either test everyone or to test a random sample of people. But currently not everyone gets tested, and testing is not random; moreover, tests are not perfect. These data challenges have led to wildly divergent predictions in recent months about how many people get infected and how many infected people die.

In research published in the Journal of Econometrics, Molinari and Charles F. Manski, the Board of Trustees Professor at Northwestern University, wrote that actual cumulative rates of COVID-19 infection are higher than reported rates of infection, and therefore actual infection fatality rates are lower than reported rates. The researchers reached these conclusions using a technique called “partial identification,” which Molinari uses often in her econometrics research.

“You are interested in some quantity, but you cannot learn it exactly,” she said. “In this particular instance, we are interested in the infection rate, and we recognize that because we don’t have a random sample, we can’t learn the exact infection rate from the data.”

She and Manski made weak but logical assumptions about COVID-19 data from Illinois, New York and Italy from March 16 to April 24, thereby putting some limits around the incomplete data.

They assumed that the infection rate among those who are tested is higher than the rate among those who are not – a logical assumption because people showing symptoms are most likely to be tested. The researchers also allowed for the possibility that many negative test results were false – i.e., that the person tested was actually positive but not counted.

These two assumptions drive the actual cumulative infection rates up and push the actual fatality rates down, Molinari said. Cumulative infection rates in New York state as of April 24, according to the researchers, were between 1.7% and 61% of the state’s 19.45 million residents (or between 330,650 and 12,020,100 people), with an upper infection fatality rate of 4.9%. That is substantially lower than the death rate among confirmed infected individuals, which on April 24 was 5.9%.

Infection rates for the same date in Illinois were between 0.04% and 52%; in Italy, they were between 0.06% and 47%.

“The bounds you get are wide,” Molinari said, “but they are substantially tighter compared to the bounds you obtain if you assume nothing about the missing data.”

Making key assumptions and narrowing the bounds helps policymakers and leaders better understand fatality rates as they try to limit spread of the virus and plan reactivations. Molinari hopes this research will contribute to serious analysis of policies.

Molinari and Manski are working on a follow-up analysis of a longer time period that adds data from California, Florida and Texas to the study.

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3327
Newswise: How to Keep Children Safe from COVID-19 this Fall
Released: 18-Sep-2020 4:15 PM EDT
How to Keep Children Safe from COVID-19 this Fall
Rush University Medical Center

With the new school year started and autumn approaching, Colleen Nash, MD, MPH, Rush University Medical Center, pediatric infectious disease specialist, answers questions parents may have about keeping children safe from COVID, social distancing in the classroom and celebrating Halloween.

Released: 18-Sep-2020 4:05 PM EDT
Claims circulating on social media stating that the common cold or flu can be mistaken for COVID-19 are misleading
Newswise

The claims rely on the faulty assumption that there is no method to distinguish COVID-19 from the common cold and the flu.

Released: 18-Sep-2020 3:35 PM EDT
After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing
University of Connecticut

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

Newswise:Video Embedded blowin-in-the-wind
VIDEO
Released: 18-Sep-2020 3:10 PM EDT
Blowin' in the wind
University of Utah

University of Utah chemical engineers have conducted an air flow study of the venue that the Utah Symphony performs in to determine the best ways to mitigate the spread of COVID-19 through the emissions of wind instrument players.

Newswise: holman1_toned-1-768x512.jpg
Released: 18-Sep-2020 2:50 PM EDT
Study links rising stress, depression in U.S. to pandemic-related losses, media consumption
University of California, Irvine

Irvine, Calif., Sept. 18, 2020 – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. The report appears in Science Advances, published by the American Association for the Advancement of Science.

Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.


Showing results

110 of 3327

close
1.40251